April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Racial Differences in Visual Function in Healthy Eyes in the African Descent and Glaucoma Evaluation Study (ADAGES)
Author Affiliations & Notes
  • L. Racette
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • J. M. Liebmann
    Ophthalmology, New York Eye and Ear Infirmary, New York, New York
  • C. A. Girkin
    Ophthalmology, University of Alabama, Birmingham, Alabama
  • L. M. Zangwill
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • S. Jain
    Family and Preventive Medicine - Division of Biostatistics and Bioinformatics,
    UC San Diego, La Jolla, California
  • F. A. Medeiros
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • C. Bowd
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • R. N. Weinreb
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • P. A. Sample
    Hamilton Glaucoma Center,
    UC San Diego, La Jolla, California
  • ADAGES Study Group
    UC San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  L. Racette, None; J.M. Liebmann, Heidelberg Engineering, R; Carl Zeiss Meditec, R; C.A. Girkin, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Optivue, F; L.M. Zangwill, Heidelberg Engineering, F; Carl Zeiss Meditec, F; Optovue, F; Nidek, F; S. Jain, None; F.A. Medeiros, Pfizer, F; Alcon, F; Carl Zeiss Meditec, F; Pfizer, C; Alcon, C; Allergan, C; Carl Zeiss Meditec, C; Pfizer, R; Alcon, R; Allergan, R; Carl Zeiss Meditec, R; Reichert Inc, R; C. Bowd, Lace Elettronica, F; R.N. Weinreb, Heidelberg Engineering, F; Carl Zeiss Meditec, F; Paradigm, F; Topcon, F; Carl Zeiss Meditec, C; P.A. Sample, Carl Zeiss Meditec, F; Welch-Allyn, F; Haag-Streit, F.
  • Footnotes
    Support  EY08208 (PAS); EY14267 (PAS); EY11008 (LMZ); EY13959 (CAG); Eyesight Foundation of Alabama (CAG); retention incentive grants in the form of cost-free medication: Alcon, Allergan, Pfizer, Merck, Santen
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 6198. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Racette, J. M. Liebmann, C. A. Girkin, L. M. Zangwill, S. Jain, F. A. Medeiros, C. Bowd, R. N. Weinreb, P. A. Sample, ADAGES Study Group; Racial Differences in Visual Function in Healthy Eyes in the African Descent and Glaucoma Evaluation Study (ADAGES). Invest. Ophthalmol. Vis. Sci. 2009;50(13):6198.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate differences in visual function between the healthy eyes of people of African (AD) and European (ED) descent.

Methods: : Visual function was assessed in both eyes (when eligible) of 393 AD and 367 ED participants selected from the African Descent and Glaucoma Evaluation Study (ADAGES) and Diagnostic Innovations in Glaucoma Study (DIGS). Participants had normal appearance of the optic disc on stereophotographs and intra-ocular pressure ≤22 mm Hg. Visual field data were not used for classification. Each participant had two reliable 24-2 tests on Standard Automated Perimetry (SAP) using the Swedish Interactive Thresholding Algorithm (SITA), Short-Wavelength Automated Perimetry (SITA and/or Full-Threshold) and Frequency-Doubling Technology (FDT Matrix) perimetry, all within a 3 month window. The average result of the two visual fields of each test is reported for Mean Deviation (MD), Pattern Standard Deviation (PSD) and proportion of abnormal Glaucoma Hemifield Test (GHT). The Generalized Estimating Equation approach was used to adjust for the inter-eye correlation.

Results: : Participants of AD (46.2±13.2 years) were significantly younger than those of ED (49.5±16.6 years) (p=0.003) and all results were adjusted for age. People of AD had significantly worse mean MD than people of ED on SWAP-SITA (AD: -3.90±3.27; ED: -3.48±3.35; p=0.02), SWAP-FT (AD: -4.40±3.25; ED: -3.73±3.32; p=0.001) and FDT (AD: -1.69±2.73; ED: -0.73±2.64; p=<.0001). They also had significantly worse mean PSD values on all tests: SAP (AD: 1.91±0.93; ED: 1.79±0.87; p=0.003); SWAP-SITA (AD: 3.06±0.96; ED: 2.89±0.83; p=0.0001); SWAP-FT (AD: 2.98±0.84; ED: 2.87±0.79; p=0.001); FDT (AD: 3.00±0.78; ED: 2.86±0.69; p=0.0001). All mean values for MD and PSD for both racial groups were within the normal range for all tests. A significantly larger proportion of people of AD had an abnormal GHT compared to people of ED for SAP (AD: 0.23±0.42; ED: 0.19±0.39; p=0.003) and FDT (AD: 0.35±0.48; ED: 0.30±0.46; p=0.008). No racial differences were found in the proportion of abnormal GHT for SWAP-SITA or SWAP-FT.

Conclusions: : People of AD had significantly worse performance than people of ED on all tests of visual function. These small differences may be signs of early disease or they may point to the need for race-specific normative database for each of the visual function tests.

Keywords: visual fields • perimetry • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×